Literature DB >> 11937014

Surgical palliation in advanced disease: recent developments.

Geoffrey P Dunn1.   

Abstract

Despite many valuable technical innovations for the relief of suffering in advanced disease over the past few years, only recently have surgical oncologists attempted to more clearly define palliation. Previous definitions have been misleading, creating confusion about the merits of surgery in many situations and difficulty in posing questions for future prospective clinical trials. This report outlines recent progress in identifying and refining a philosophy of palliative surgery that would align it with the consensus of nonsurgical opinion summarized by the 1990 World Health Organization definition of palliative care and the emerging consensus among the medical specialties in the United States concerning principles of care at the end of life. Selected controversies and recent innovations, as well as guidelines for palliative surgery, are discussed.

Mesh:

Year:  2002        PMID: 11937014     DOI: 10.1007/s11912-002-0021-3

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  64 in total

Review 1.  Communication: part of the surgical armamentarium.

Authors:  R A Milch; G P Dunn
Journal:  J Am Coll Surg       Date:  2001-10       Impact factor: 6.113

2.  Anaplastic giant cell carcinoma of the thyroid gland: treatment and survival over a 25-year period.

Authors:  O Nilsson; J Lindeberg; J Zedenius; E Ekman; J Tennvall; H Blomgren; L Grimelius; G Lundell; G Wallin
Journal:  World J Surg       Date:  1998-07       Impact factor: 3.352

Review 3.  An update in the palliative management of malignant dysphagia.

Authors:  A K Kubba; N Krasner
Journal:  Eur J Surg Oncol       Date:  2000-03       Impact factor: 4.424

4.  Survival and quality of life after palliative surgery for neoplastic gastrointestinal obstruction.

Authors:  H Legendre; F Vanhuyse; F X Caroli-Bosc; J C Pector
Journal:  Eur J Surg Oncol       Date:  2001-06       Impact factor: 4.424

5.  Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans.

Authors:  H Tamai; K Igaki; E Kyo; K Kosuga; A Kawashima; S Matsui; H Komori; T Tsuji; S Motohara; H Uehata
Journal:  Circulation       Date:  2000-07-25       Impact factor: 29.690

6.  Positive peritoneal cytology predicts unresectability of pancreatic adenocarcinoma.

Authors:  N B Merchant; K C Conlon; P Saigo; E Dougherty; M F Brennan
Journal:  J Am Coll Surg       Date:  1999-04       Impact factor: 6.113

Review 7.  Metallic stents in the treatment of duodenal obstruction: technical issues and results.

Authors:  S B Singer; M Asch
Journal:  Can Assoc Radiol J       Date:  2000-04       Impact factor: 2.248

8.  Thoracoscopic splanchnicectomy for pain relief in unresectable pancreatic cancer.

Authors:  A Pietrabissa; F Vistoli; A Carobbi; U Boggi; M Bisà; F Mosca
Journal:  Arch Surg       Date:  2000-03

9.  Risks and benefits of splenectomy in myelofibrosis with myeloid metaplasia: a retrospective analysis of 26 cases.

Authors:  G Akpek; D McAneny; L Weintraub
Journal:  J Surg Oncol       Date:  2001-05       Impact factor: 3.454

10.  Quality of life assessment of patients in extremity sarcoma clinical trials.

Authors:  P H Sugarbaker; I Barofsky; S A Rosenberg; F J Gianola
Journal:  Surgery       Date:  1982-01       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.